Replies to post #773209 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Agreed. Non dilutive funding is the key. Even a UK approval will not bring sustainable share price. We will likely get a small spike that lasts day(s) and then it starts moving in the opposite direction. The share price will ultimately be much lower than before approval as quarter after quarter of disappointing revenues are reported coupled with endless dilution.

[FeMike]

The market will only respond to approval news and better yet huge non-dilutive financial injection into NWBO following that.
Now, yes, the market seems to start considering rejection.

I mean, you say that, but the market ran the stock up 180% not two months ago on news that Stuttgart, an obscure German trading platform with about $3,000 a day traded on NWBO, suspended NWBO trading.

It ran 180% in two weeks. 180%. That's massive.

This ticker is looking for literally any reason to run. Any reason at all. It's not waiting for approval, it's itching to move, and it still can't. That says something.